| Organism name | Tordylium apulum | 
|---|---|
| Genus | Tordylium | 
| Family | Apiaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Tordylium apulum | 
|---|---|
| Linked NCBI taxonomy ID | 489417 | 
| Linked level | species | 
| Family in NCBI taxonomy | Apiaceae | 
|---|---|
| ID | 4037 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | asterids | 
|---|---|
| ID | 71274 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00005548   | Narcissin / Isorhamnetin 3-O-rutinoside | CHEMBL84174 CHEMBL258394 CHEMBL1711509 CHEMBL2165403 | C031062 | 7 / 1 / 2 | No. 1 | No. 15 |   | |
| C00013882   | Quercetin 3-(3'',4''-diacetylrhamnosyl)-(1->6)-glucoside | No. 1 | No. 15 |   | ||||
| C00005413   | Rutin / Birutan / 3-Rutinosylquercetin / Quercetin 3-O-rutinoside / (+)-Quercetin 3-O-rutinoside / Quercetin 3-O-beta-rutinoside / (+)-Quercetin 3-O-beta-rutinoside / 3,3',4',5,7-Pentahydroxyflavone 3-rutinoside / Quercetin 3-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside | CHEMBL32579 CHEMBL310754 CHEMBL182108 CHEMBL226335 CHEMBL502782 CHEMBL1436093 CHEMBL1532989 | D012431 | 25 / 18 / 16 | 29 / 8 | No. 1 | No. 15 |   | 
| C00005169   | Nicotiflorin / Nicotifloroside / Kaempferol 3-O-rutinoside / Kaempferol 3-O-(alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranoside / (-)-Kaempferol 3-O-(alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranoside | CHEMBL431610 CHEMBL79790 CHEMBL255020 CHEMBL501550 CHEMBL498879 CHEMBL1419228 CHEMBL1875691 | 22 / 10 / 12 | No. 1 | No. 15 |   | ||
| C00000583   | Isopimpinellin | CHEMBL140796 | C015304 | 9 / 3 / 4 | 2 / 0 | No. 606 | No. 25 |   | 
| C00002503   | Umbelliferon / Umbelliferone / 7-Hydroxycoumarin | CHEMBL51628 | C031477 | 39 / 33 / 32 | 9 / 0 | No. 1030 | No. 25 |   | 
| C00000576   | Xanthotoxin | CHEMBL416 | D008730 | 104 / 55 / 45 | 22 / 18 | No. 1282 | No. 25 |   | 
| C00037321   | Isobergapten | CHEMBL141690 | 8 / 5 / 4 | No. 1282 | No. 25 |   | ||
| C00035183   | Columbianetin acetate | C076302 | No. 1319 | No. 25 |   | |||
| C00044128   | Cnidiadin | No. 1319 | No. 25 |   | ||||
| C00029297   | Columbianetin / (+)-Columbianetin | CHEMBL201152 | 7 / 12 / 8 | No. 1336 | No. 25 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000576 C00000583 C00005413 C00005548 C00037321 | 0 / 1 | 
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000583 C00002503 C00005413 C00029297 C00037321 | 0 / 0 | 
| P56817 | Beta-secretase 1 | A1A | C00000576 C00000583 C00002503 C00029297 | 0 / 0 | 
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002503 C00005169 C00005413 C00029297 | 1 / 1 | 
| O75496 | Geminin | Unclassified protein | C00002503 C00005169 C00005548 C00037321 | 0 / 0 | 
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000583 C00005169 C00005413 | 0 / 0 | 
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00002503 C00005169 C00005413 | 1 / 1 | 
| P06746 | DNA polymerase beta | Enzyme | C00000583 C00005169 C00005413 | 0 / 0 | 
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000583 C00002503 C00029297 | 2 / 2 | 
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00002503 C00029297 C00037321 | 0 / 0 | 
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000576 C00002503 C00005413 | 0 / 3 | 
| P22303 | Acetylcholinesterase | Hydrolase | C00000576 C00002503 C00005413 | 1 / 0 | 
| P03372 | Estrogen receptor | NR3A1 | C00000576 C00005413 C00005548 | 1 / 1 | 
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00000576 C00000583 | 1 / 1 | 
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002503 C00005413 | 3 / 3 | 
| Q9UNA4 | DNA polymerase iota | Enzyme | C00005169 C00005548 | 0 / 0 | 
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00005413 C00037321 | 4 / 3 | 
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00000576 C00005413 | 0 / 0 | 
| Q99700 | Ataxin-2 | Unclassified protein | C00002503 C00005169 | 1 / 1 | 
| P29466 | Caspase-1 | C14 | C00000576 C00002503 | 0 / 0 | 
| P14679 | Tyrosinase | Oxidoreductase | C00002503 C00005413 | 4 / 2 | 
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00005413 C00037321 | 0 / 0 | 
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000576 C00002503 | 0 / 0 | 
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00000576 C00029297 | 7 / 3 | 
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00000576 C00005548 | 0 / 0 | 
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000576 C00005413 | 0 / 0 | 
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00005169 C00005413 | 0 / 0 | 
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00005413 C00037321 | 0 / 0 | 
| P00918 | Carbonic anhydrase 2 | Lyase | C00000576 C00002503 | 1 / 2 | 
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000583 C00002503 | 0 / 0 | 
| P39748 | Flap endonuclease 1 | Enzyme | C00002503 C00005169 | 0 / 0 | 
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002503 C00005169 | 0 / 0 | 
| P11473 | Vitamin D3 receptor | NR1I1 | C00000576 C00005169 | 2 / 3 | 
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00005169 C00005413 | 1 / 0 | 
| P07237 | Protein disulfide-isomerase | Enzyme | C00005169 C00005548 | 0 / 0 | 
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000576 C00005413 | 0 / 0 | 
| P27487 | Dipeptidyl peptidase 4 | S9B | C00005413 | 0 / 1 | 
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000576 | 0 / 0 | 
| P06241 | Tyrosine-protein kinase Fyn | Src | C00000576 | 0 / 0 | 
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000576 | 0 / 0 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000576 | 0 / 1 | 
| P23443 | Ribosomal protein S6 kinase beta-1 | p70 | C00000576 | 0 / 0 | 
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000576 | 0 / 0 | 
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000576 | 1 / 0 | 
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000576 | 1 / 8 | 
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00005413 | 0 / 0 | 
| P35367 | Histamine H1 receptor | Histamine receptor | C00000576 | 0 / 0 | 
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00000576 | 2 / 0 | 
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000576 | 0 / 0 | 
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000576 | 0 / 0 | 
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00000576 | 0 / 0 | 
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000576 | 0 / 0 | 
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00000576 | 0 / 0 | 
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000576 | 0 / 0 | 
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000576 | 1 / 1 | 
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000576 | 0 / 0 | 
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000576 | 1 / 0 | 
| P25021 | Histamine H2 receptor | Histamine receptor | C00000576 | 0 / 0 | 
| P28845 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | Enzyme | C00002503 | 1 / 1 | 
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00029297 | 2 / 2 | 
| O43570 | Carbonic anhydrase 12 | Lyase | C00002503 | 1 / 2 | 
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000576 | 0 / 0 | 
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000576 | 1 / 1 | 
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000576 | 0 / 1 | 
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00000576 | 3 / 2 | 
| P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00002503 | 0 / 0 | 
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000576 | 0 / 0 | 
| P20813 | Cytochrome P450 2B6 | Cytochrome P450 2B6 | C00000576 | 1 / 0 | 
| P18405 | 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Oxidoreductase | C00002503 | 0 / 0 | 
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00000576 | 0 / 0 | 
| P30988 | Calcitonin receptor | Calcitonin receptor | C00000576 | 0 / 0 | 
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00000576 | 1 / 0 | 
| P41143 | Delta-type opioid receptor | Opioid receptor | C00000576 | 0 / 0 | 
| Q92731 | Estrogen receptor beta | NR3A2 | C00000576 | 0 / 1 | 
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000576 | 0 / 0 | 
| P15121 | Aldose reductase | Enzyme | C00002503 | 0 / 0 | 
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00000576 | 0 / 0 | 
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000576 | 0 / 0 | 
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000576 | 1 / 0 | 
| P00915 | Carbonic anhydrase 1 | Lyase | C00002503 | 0 / 0 | 
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000576 | 0 / 0 | 
| P08311 | Cathepsin G | S1A | C00000576 | 0 / 0 | 
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000576 | 0 / 0 | 
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000576 | 1 / 0 | 
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00005169 | 0 / 0 | 
| P03956 | Interstitial collagenase | M10A | C00000576 | 0 / 1 | 
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000576 | 0 / 0 | 
| P14780 | Matrix metalloproteinase-9 | M10A | C00000576 | 2 / 2 | 
| Q9Y253 | DNA polymerase eta | Enzyme | C00005169 | 1 / 1 | 
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00005169 | 0 / 0 | 
| P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00002503 | 0 / 0 | 
| Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00000576 | 1 / 0 | 
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00000576 | 0 / 0 | 
| P04150 | Glucocorticoid receptor | NR3C1 | C00000576 | 0 / 1 | 
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000576 | 2 / 0 | 
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000576 | 0 / 0 | 
| P17252 | Protein kinase C alpha type | Alpha | C00000576 | 0 / 0 | 
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000576 | 0 / 0 | 
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000576 | 2 / 0 | 
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000576 | 5 / 9 | 
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000576 | 1 / 0 | 
| P21452 | Substance-K receptor | Neurokinin receptor | C00000576 | 0 / 0 | 
| P06276 | Cholinesterase | Hydrolase | C00005413 | 0 / 0 | 
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000576 | 0 / 0 | 
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000576 | 3 / 0 | 
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000576 | 0 / 0 | 
| P06280 | Alpha-galactosidase A | Enzyme | C00002503 | 1 / 1 | 
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000576 | 1 / 0 | 
| P04062 | Glucosylceramidase | Enzyme | C00002503 | 6 / 4 | 
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000576 | 2 / 1 | 
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000576 | 0 / 0 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000576 | 0 / 0 | 
| Q16790 | Carbonic anhydrase 9 | Lyase | C00002503 | 0 / 1 | 
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000576 | 0 / 0 | 
| Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00005413 | 2 / 0 | 
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00000576 | 0 / 0 | 
| P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00000576 | 0 / 0 | 
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00005548 | 0 / 0 | 
| Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00002503 | 0 / 0 | 
| Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00002503 | 0 / 0 | 
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000576 | 0 / 0 | 
| P08246 | Neutrophil elastase | S1A | C00000576 | 2 / 1 | 
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000576 | 1 / 0 | 
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000576 | 2 / 2 | 
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000576 | 0 / 0 | 
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000576 | 0 / 0 | 
| P35372 | Mu-type opioid receptor | Opioid receptor | C00000576 | 0 / 0 | 
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000576 | 0 / 0 | 
| P25103 | Substance-P receptor | Neurokinin receptor | C00000576 | 0 / 0 | 
| P25105 | Platelet-activating factor receptor | PAF receptor | C00000576 | 0 / 0 | 
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000576 | 0 / 0 | 
| Q00796 | Sorbitol dehydrogenase | Enzyme | C00002503 | 0 / 0 | 
| P55210 | Caspase-7 | C14 | C00002503 | 0 / 0 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000576 | 1 / 1 | 
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000576 | 0 / 0 | 
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000576 | 0 / 0 | 
| Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00002503 | 0 / 0 | 
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00005169 | 0 / 0 | 
| O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000576 | 0 / 0 | 
| P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002503 | 5 / 1 | 
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00005169 | 0 / 0 | 
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000583 | 0 / 0 | 
| P10275 | Androgen receptor | NR3C4 | C00000576 | 3 / 4 | 
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000576 | 1 / 1 | 
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000576 | 0 / 0 | 
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00000576 | 0 / 0 | 
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000576 | 0 / 0 | 
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000576 | 1 / 1 | 
| P06239 | Tyrosine-protein kinase Lck | Src | C00000576 | 0 / 1 | 
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000576 | 0 / 0 | 
| P48147 | Prolyl endopeptidase | S9A | C00005413 | 0 / 0 | 
| P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00002503 | 1 / 1 | 
| Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00000576 | 1 / 0 | 
| P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00002503 | 3 / 0 | 
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00005169 | 0 / 0 | 
| Q09470 | Potassium voltage-gated channel subfamily A member 1 | KCNA, Kv1.x (Shaker) | C00000576 | 1 / 1 | 
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002503 | 1 / 1 | 
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00037321 | 1 / 0 | 
| O00255 | Menin | Unclassified protein | C00002503 | 2 / 5 | 
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002503 | 1 / 2 | 
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00005169 | 0 / 1 | 
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00005169 | 1 / 4 | 
| P33527 | Multidrug resistance-associated protein 1 | drugs | C00005413 | 0 / 0 | 
| Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00005169 | 2 / 1 | 
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000576 | 1 / 0 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 581 | BAX, BCL2L4 | BCL2-associated X protein | C00000576
                          C00002503
                          C00005413 | 
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 | C00000576
                          C00002503
                          C00005413 | 
| 1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | C00000583
                          C00005413 | 
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | C00000576
                          C00005413 | 
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor | C00000576
                          C00005413 | 
| 8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 | C00000576
                          C00000583 | 
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | C00000576
                          C00005413 | 
| 1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) | C00000576
                          C00002503 | 
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 | C00000576 | 
| 54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) | C00002503 | 
| 7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) | C00002503 | 
| 8553 | BHLHE40, BHLHB2, DEC1, HLHB2, SHARP-2, STRA13, Stra14 | basic helix-loop-helix family, member e40 | C00000576 | 
| 332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 | C00000576 | 
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 | C00002503 | 
| 841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | C00000576 | 
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | C00000576 | 
| 1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | C00000576 | 
| 8824 | CES2, CE-2, CES2A1, PCE-2, iCE | carboxylesterase 2 (EC:3.1.1.1 3.1.1.84 3.1.1.56) | C00000576 | 
| 8574 | AKR7A2, AFAR, AFAR1, AFB1-AR1, AKR7 | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) (EC:1.1.1.n11) | C00002503 | 
| 1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | C00000576 | 
| 1553 | CYP2A13, CPAD, CYP2A, CYPIIA13 | cytochrome P450, family 2, subfamily A, polypeptide 13 (EC:1.14.14.1) | C00000576 | 
| 1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) | C00000576 | 
| 1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) | C00000576 | 
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | C00000576 | 
| 3034 | HAL, HIS, HSTD | histidine ammonia-lyase (EC:4.3.1.3) | C00000576 | 
| 3355109 | C00000576 | ||
| 6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) | C00002503 | 
| 8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) | C00002503 | 
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 | C00000576 | 
| 177 | AGER, RAGE | advanced glycosylation end product-specific receptor | C00005413 | 
| 196 | AHR, bHLHe76 | aryl hydrocarbon receptor | C00005413 | 
| 405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator | C00005413 | 
| 847 | CAT | catalase (EC:1.11.1.6) | C00005413 | 
| 873 | CBR1, CBR, SDR21C1, hCBR1 | carbonyl reductase 1 (EC:1.1.1.189 1.1.1.197 1.1.1.184) | C00005413 | 
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 | C00005413 | 
| 3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 | C00005413 | 
| 1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) | C00005413 | 
| 2936 | GSR | glutathione reductase (EC:1.8.1.7) | C00005413 | 
| 3458 | IFNG, IFG, IFI | interferon, gamma | C00005413 | 
| 3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) | C00005413 | 
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta | C00005413 | 
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) | C00005413 | 
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 | C00005413 | 
| 3667 | IRS1, HIRS-1 | insulin receptor substrate 1 | C00005413 | 
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene | C00005413 | 
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) | C00005413 | 
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) | C00005413 | 
| 4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | C00005413 | 
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | C00005413 | 
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A | C00005413 | 
| 7039 | TGFA, TFGA | transforming growth factor, alpha | C00005413 | 
| 7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A | C00005413 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency | Q99714 | 
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism | P20309 | 
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah | P63092 | 
| #103470 | Albinism, ocular, with sensorineural deafness | P14679 | 
| #203100 | Albinism, oculocutaneous, type ia; oca1a | P14679 | 
| #606952 | Albinism, oculocutaneous, type ib; oca1b | P14679 | 
| #103780 | Alcohol dependence | P08172 P14416 P31645 | 
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 | Q13148 | 
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 | Q99720 | 
| #300068 | Androgen insensitivity syndrome; ais | P10275 | 
| #312300 | Androgen insensitivity, partial; pais | P10275 | 
| #218030 | Apparent mineralocorticoid excess; ame | P80365 | 
| #601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 | P22309 | 
| #614490 | Blood group, junior system; jr | Q9UNQ0 | 
| #602025 | Body mass index quantitative trait locus 9; bmiq9 | P41968 | 
| #300615 | Brunner syndrome | P21397 | 
| #114500 | Colorectal cancer; crc | Q14191 | 
| #604931 | Cortisone reductase deficiency 1; cortrd1 | P28845 | 
| #218800 | Crigler-najjar syndrome, type i | P22309 P22310 | 
| #606785 | Crigler-najjar syndrome, type ii | P22309 P22310 | 
| #162800 | Cyclic neutropenia | P08246 | 
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 | P51681 | 
| #119900 | Digital clubbing, isolated congenital | P15428 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #614546 | Efavirenz, poor metabolism of | P20813 | 
| #160120 | Episodic ataxia, type 1; ea1 | Q09470 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #301500 | Fabry disease | P06280 | 
| #600274 | Frontotemporal dementia; ftd | P10636 | 
| #613659 | Gastric cancer | P04626 | 
| #137215 | Gastric cancer, hereditary diffuse; hdgc | P04626 | 
| #608013 | Gaucher disease, perinatal lethal | P04062 | 
| #230800 | Gaucher disease, type i | P04062 | 
| #230900 | Gaucher disease, type ii | P04062 | 
| #231000 | Gaucher disease, type iii | P04062 | 
| #231005 | Gaucher disease, type iiic | P04062 | 
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd | P24557 | 
| #143500 | Gilbert syndrome | P22309 P22310 | 
| #137800 | Glioma susceptibility 1; glm1 | O75874 P04626 | 
| #232300 | Glycogen storage disease ii | P10253 | 
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay | Q03164 | 
| #609423 | Human immunodeficiency virus type 1, susceptibility to | P41597 P51681 | 
| #237450 | Hyperbilirubinemia, rotor type; hblrr | Q9NPD5 Q9Y6L6 | 
| #237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn | P22309 | 
| #143860 | Hyperchlorhidrosis, isolated | O43570 | 
| #145000 | Hyperparathyroidism 1; hrpt1 | O00255 | 
| #603373 | Hyperthyroidism, familial gestational | P16473 | 
| #609152 | Hyperthyroidism, nonautoimmune | P16473 | 
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 | P15428 | 
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 | P16473 | 
| #603932 | Intervertebral disc disease; idd | P14780 | 
| #613688 | Long qt syndrome 2; lqt2 | Q12809 | 
| #211980 | Lung cancer | P00533 P04626 | 
| #608516 | Major depressive disorder; mdd | P08172 | 
| #174800 | Mccune-albright syndrome; mas | P63092 | 
| #300705 | Mental retardation, x-linked 17; mrx17 | Q99714 | 
| %300852 | Mental retardation, x-linked 88; mrx88 | P50052 | 
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 | Q99714 | 
| #613073 | Metaphyseal anadysplasia 2; mandp2 | P14780 | 
| #131100 | Multiple endocrine neoplasia, type i; men1 | O00255 | 
| #126200 | Multiple sclerosis, susceptibility to; ms | P08575 | 
| #607948 | Mycobacterium tuberculosis, susceptibility to | P11473 | 
| #159900 | Myoclonic dystonia | P14416 | 
| #160900 | Myotonic dystrophy 1; dm1 | Q9NR56 | 
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 | P08246 | 
| #257200 | Niemann-pick disease, type a | P17405 | 
| #607616 | Niemann-pick disease, type b | P17405 | 
| #601665 | Obesity | P32245 | 
| #164230 | Obsessive-compulsive disorder; ocd | P31645 | 
| #604715 | Orthostatic intolerance | P23975 | 
| #166350 | Osseous heteroplasia, progressive; poh | P63092 | 
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 | P00918 | 
| #167000 | Ovarian cancer | P04626 | 
| #168600 | Parkinson disease, late-onset; pd | P04062 | 
| #260540 | Parkinson-dementia syndrome | P10636 | 
| #613135 | Parkinsonism-dystonia, infantile; pkdys | Q01959 | 
| #172700 | Pick disease of brain | P10636 | 
| #102200 | Pituitary adenoma, growth hormone-secreting | P63092 | 
| #601399 | Platelet disorder, familial, with associated myeloid malignancy | Q01196 | 
| #103580 | Pseudohypoparathyroidism, type ia; php1a | P63092 | 
| #603233 | Pseudohypoparathyroidism, type ib; php1b | P63092 | 
| #612462 | Pseudohypoparathyroidism, type ic; php1c | P63092 | 
| #607276 | Resting heart rate, variation in | P08588 | 
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive | P08575 | 
| #609620 | Short qt syndrome 1; sqt1 | Q12809 | 
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 | P14679 | 
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 | P10275 | 
| #183090 | Spinocerebellar ataxia 2; sca2 | Q99700 | 
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 | Q9NUW8 | 
| #601104 | Supranuclear palsy, progressive, 1; psnp1 | P10636 | 
| #190300 | Tremor, hereditary essential, 1; etm1 | P35462 | 
| #138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 | Q9UNQ0 | 
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a | P11473 | 
| #277700 | Werner syndrome; wrn | Q14191 | 
| #610379 | West nile virus, susceptibility to | P51681 | 
| #278300 | Xanthinuria, type i | P47989 | 
| #278750 | Xeroderma pigmentosum, variant type; xpv | Q9Y253 | 
| #112100 | Yt blood group antigen | P22303 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00033 | Adrenal carcinoma | O00255
                            (related) | 
| H00034 | Carcinoid | O00255
                            (related) | 
| H00045 | Malignant islet cell carcinoma | O00255
                            (related) | 
| H00246 | Primary hyperparathyroidism | O00255
                            (related) | 
| H01102 | Pituitary adenomas | O00255
                            (related) | 
| H01302 | Hyperchlorhidrosis isolated (HCHLH) | O43570
                            (related) | 
| H00021 | Renal cell carcinoma | O43570
                            (marker) Q16790 (marker) | 
| H00016 | Oral cancer | P00533
                            (related) P00533 (marker) | 
| H00017 | Esophageal cancer | P00533
                            (related) P35354 (related) | 
| H00018 | Gastric cancer | P00533
                            (related) P04626 (related) | 
| H00022 | Bladder cancer | P00533
                            (related) P04626 (related) | 
| H00028 | Choriocarcinoma | P00533
                            (related) P03956 (related) P04626 (related) | 
| H00030 | Cervical cancer | P00533
                            (related) P04626 (related) | 
| H00042 | Glioma | P00533
                            (related) P00533 (marker) | 
| H00055 | Laryngeal cancer | P00533
                            (related) P00533 (marker) | 
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) | P00918
                            (related) | 
| H00436 | Osteopetrosis | P00918
                            (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) P04626 (related) Q92731 (marker) | 
| H00066 | Lewy body dementia (LBD) | P04062
                            (related) | 
| H00126 | Gaucher disease | P04062
                            (related) | 
| H00426 | Defects in the degradation of ganglioside | P04062
                            (related) | 
| H00810 | Progressive myoclonic epilepsy (PME) | P04062
                            (related) | 
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) | P04150
                            (related) | 
| H00019 | Pancreatic cancer | P04626
                            (related) | 
| H00027 | Ovarian cancer | P04626
                            (related) | 
| H00031 | Breast cancer | P04626
                            (related) P04626 (marker) | 
| H00046 | Cholangiocarcinoma | P04626
                            (related) P35354 (related) | 
| H00093 | Combined immunodeficiencies (CIDs) | P06239
                            (related) | 
| H00125 | Fabry disease | P06280
                            (related) | 
| H00079 | Asthma | P07550
                            (related) | 
| H00100 | Neutropenic disorders | P08246
                            (related) | 
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) | P08575
                            (related) | 
| H00036 | Osteosarcoma | P08684
                            (marker) | 
| H00069 | Glycogen storage diseases (GSD) | P10253
                            (related) | 
| H00024 | Prostate cancer | P10275
                            (related) | 
| H00062 | Spinal and bulbar muscular atrophy (SBMA) | P10275
                            (related) | 
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) | P10275
                            (related) | 
| H00609 | 46,XY disorders of sex development (Other) | P10275
                            (related) | 
| H00058 | Amyotrophic lateral sclerosis (ALS) | P10636
                            (related) Q13148 (related) | 
| H00077 | Progressive supranuclear palsy (PSP) | P10636
                            (related) | 
| H00078 | Frontotemporal lobar degeneration (FTLD) | P10636
                            (related) | 
| H00342 | Tuberculosis | P11473
                            (related) | 
| H00784 | Localized autosomal recessive hypotrichosis | P11473
                            (related) | 
| H01143 | Vitamin D-dependent rickets | P11473
                            (related) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H00168 | Oculocutaneous albinism (OCA) | P14679
                            (related) | 
| H00038 | Malignant melanoma | P14679
                            (marker) | 
| H00025 | Penile cancer | P14780
                            (related) P35354 (related) | 
| H00479 | Metaphyseal dysplasias | P14780
                            (related) | 
| H00457 | Primary hypertrophic osteoarthropathy (PHO) | P15428
                            (related) | 
| H01246 | Isolated congenital nail clubbing (ICNC) | P15428
                            (related) | 
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) | P16473
                            (related) | 
| H01269 | Congenital hyperthyroidism | P16473
                            (related) | 
| H00137 | Niemann-Pick disease (NPD) typeA and B | P17405
                            (related) | 
| H00424 | Defects in the degradation of sphingomyelin | P17405
                            (related) | 
| H00548 | Brunner syndrome | P21397
                            (related) | 
| H00208 | Hyperbilirubinemia | P22309
                            (related) | 
| H01031 | Orthostatic intolerance (OI) | P23975
                            (related) | 
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) | P24557
                            (related) | 
| H00032 | Thyroid cancer | P27487
                            (marker) | 
| H01111 | Cortisone reductase deficiency (CRD) | P28845
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00192 | Xanthinuria | P47989
                            (related) | 
| H00480 | Non-syndromic X-linked mental retardation | P50052
                            (related) Q99714 (related) | 
| H00244 | Pseudohypoparathyroidism | P63092
                            (related) | 
| H00441 | Progressive osseous heteroplasia (POH) | P63092
                            (related) | 
| H00501 | Fibrous dysplasia, polyostotic | P63092
                            (related) | 
| H00259 | Apparent mineralocorticoid excess syndrome | P80365
                            (related) | 
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) | Q01196
                            (related) Q01196 (marker) Q03164 (related) Q03164 (marker) | 
| H00003 | Acute myeloid leukemia (AML) | Q01196
                            (related) Q01196 (marker) Q13951 (marker) | 
| H00004 | Chronic myeloid leukemia (CML) | Q01196
                            (related) | 
| H00978 | Thrombocytopenia (THC) | Q01196
                            (related) | 
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) | Q03164
                            (related) | 
| H00749 | Episodic ataxias | Q09470
                            (related) | 
| H00720 | Long QT syndrome | Q12809
                            (related) | 
| H00725 | Short QT syndrome | Q12809
                            (related) | 
| H00296 | Defects in RecQ helicases | Q14191
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | Q99700
                            (related) Q9NUW8 (related) | 
| H00658 | Syndromic X-linked mental retardation | Q99714
                            (related) | 
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency | Q99714
                            (related) | 
| H00403 | Disorders of nucleotide excision repair | Q9Y253
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D007674 | Kidney Diseases | C00000576 C00005413 | 
| D011565 | Psoriasis | C00000576 | 
| D004485 | Eczema | C00000576 | 
| D006261 | Headache | C00000576 | 
| D015746 | Abdominal Pain | C00000576 | 
| D017114 | Liver Failure, Acute | C00000576 | 
| D008175 | Lung Neoplasms | C00000576 | 
| D016410 | Lymphoma, T-Cell, Cutaneous | C00000576 | 
| D008881 | Migraine Disorders | C00000576 | 
| D009182 | Mycosis Fungoides | C00000576 | 
| D009325 | Nausea | C00000576 | 
| D000857 | Olfaction Disorders | C00000576 | 
| D056486 | Drug-Induced Liver Injury | C00000576 | 
| D011693 | Purpura | C00000576 | 
| D007319 | Sleep Initiation and Maintenance Disorders | C00000576 | 
| D014006 | Tinea Capitis | C00000576 | 
| D015837 | Vestibular Diseases | C00000576 | 
| D014820 | Vitiligo | C00000576 | 
| D001424 | Bacterial Infections | C00005413 | 
| D003092 | Colitis | C00005413 | 
| D004409 | Dyskinesia, Drug-Induced | C00005413 | 
| D015212 | Inflammatory Bowel Diseases | C00005413 | 
| D028361 | Mitochondrial Diseases | C00005413 | 
| D010243 | Paralysis | C00005413 | 
| D013276 | Stomach Ulcer | C00005413 |